InsidersTradesSigma
Follow the 迈得医疗 share price and the full management transaction log of the company, a publicly traded company based in China. Shares trade on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 迈得医疗 has published 3 reports. Market capitalisation: €2.2bn. The latest transaction was disclosed on 12 August 2025 (Sale). Among the most active insiders: 王瑜玲. All data is free.
3
Insider Decl.
n/a
Thresholds
€739,315
2 ops.
Buy Volume
€50,969
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 13,287 of 28,958 companies
54.2
score / 100
Value44
Quality64
FCF yld4.4%
Earn yld2.9%
EV/EBITDA23.3x
ROE4.1%
Gross mgn45%
Net mgn15%
Debt/EBITDA0.6x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 12 August 2025
About 迈得医疗
迈得医疗 is a company in the healthcare and pharmaceutical sector, listed on the Shanghai Stock Exchange. It focuses on the development and manufacturing of innovative medical devices.